Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT04091412

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04091412
Other papers using this trial's data
  • Collateral Circulation and Rabep2 Polymorphisms in Large Artery Occlusion: Impacts on Short- and Long-Term Prognosis Journal of the American Heart Association, 2025-04-15 DOI, PubMed 40207533, PMC12132831 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04091412. Randomized; double masking; primary purpose prevention. Start 2019-05-05 (actual); primary completion 2020-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion
Condition
Collateral Circulation
Condition
Large-artery Occlusion
Condition
Cerebral Infarction
Intervention (Drug)
Butylphthalide Soft Capsules
Lead sponsor
The Second Hospital of Hebei Medical University (class: other)

Record details

Record id
cardio:ct-nct04091412
Content hash
3a71ae2ec5358f3166bd11d5b1ad7282d82cd40bcf8ab2420879a31ea6dd0772